WallStreetZenWallStreetZen

NASDAQ: ABEO
Abeona Therapeutics Inc Stock Ownership - Who owns Abeona Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Abeona Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Leila AllandDirector2026-02-0218,065$5.09
$91.97kSell
Mark AlvinoDirector2026-02-022,000$5.09
$10.18kSell
Eric CrombezDirector2026-02-0216,284$5.09
$82.90kSell
Christine Berni SilversteinDirector2026-02-0220,070$5.09
$102.18kSell
Donald A. WuchterlDirector2026-02-0214,814$5.09
$75.42kSell
Brendan M. OmalleySVP Chief Legal Officer2026-01-2213,578$5.33
$72.38kSell
Madhav VasanthavadaChief Commercial Officer2026-01-2212,610$5.29
$66.66kSell
Vishwas SeshadriChief Executive Officer2026-01-2269,832$5.33
$372.27kSell
Joseph Walter VazzanoChief Financial Officer2026-01-2218,666$5.33
$99.51kSell
Mark AlvinoDirector2026-01-2113,500$5.23
$70.58kSell

1 of 4

ABEO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ABEO insiders and whales buy or sell their stock.

ABEO Shareholders

What type of owners hold Abeona Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Sco Capital Partners LLC26.55%14,390,007$73.82MInsider
Steven H. Rouhandeh25.79%13,977,076$71.70MInsider
Nantahala Capital Management LLC8.42%4,564,665$23.42MInstitution
Adage Capital Partners GP LLC6.00%3,249,994$16.67MInsider
Blackrock Inc5.81%3,147,150$16.14MInstitution
Adage Capital Partners GP LLC5.62%3,047,985$15.64MInstitution
Suvretta Capital Management LLC4.94%2,676,000$13.73MInstitution
Vanguard Group Inc4.80%2,602,901$13.35MInstitution
Ayer Capital Management LP4.45%2,413,163$12.38MInsider
B. Davis Jeffrey3.55%1,926,170$9.88MInsider

1 of 3

ABEO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ABEO45.18%54.82%Net SellingNet Selling
AARD43.48%46.96%Net BuyingNet Buying
CLLS11.49%0.00%
XOMA18.93%81.07%Net SellingNet Buying
RZLT44.64%55.36%Net BuyingNet Buying
View Top Biotech Stocks

Abeona Therapeutics Stock Ownership FAQ

Who owns Abeona Therapeutics?

Abeona Therapeutics (NASDAQ: ABEO) is owned by 65.67% institutional shareholders, 79.69% Abeona Therapeutics insiders, and 0.00% retail investors. Sco Capital Partners LLC is the largest individual Abeona Therapeutics shareholder, owning 14.39M shares representing 26.55% of the company. Sco Capital Partners LLC's Abeona Therapeutics shares are currently valued at $73.68M.

If you're new to stock investing, here's how to buy Abeona Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.